MMP‐12 was selected because its expression is increased in CRC,36 in patients with high MMP‐12 expression prognosis is associated with ITGB6 expression (Figure 5C), and MMP‐12 is commercially available. Here, ITGB6 is linked to colorectal carcinoma.